Drawing for EVIDA LABS

USPTO serial 90888073

EVIDA LABS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CROSS, TRACY L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EVIDA LABS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kelley B. Harrington

Kelley B. Harrington Cooley LLP1299 Pennsylvania Avenue, NW, Suite 700ATTN: IP Docketing DepartmentWashington, DC 20004-2400

Goods and services

ClassDescriptionStatusFirst use
042Medical laboratory testing and research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials to medical and research professionals; providing a website featuring information about medical diagnostics; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; pharmaceutical and medical research services; providing medical and scientific research information in the fields of pharmaceuticals and geneticsACTIVE—
044Medical services, namely, medical diagnostic, evaluation and screening services; disease management services; medical services, namely, providing medical information to health care providers, managed care providers and patients via global computer networks; providing health information in the field of gastrointestinal diseases, colitis, crohn's disease, and other diseases of the immune, digestive, bowel and gastrointestinal systems; providing information relating to medical diagnostic testing; medical consultation; providing a website featuring information about services for the diagnosis, prevention, and treatment of gastro-intestinal diseases, colitis, crohn's disease, and other diseases of the immune, digestive, bowel, and gastrointestinal systemsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 3, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 3, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 8, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 8, 2025EX5GSOU EXTENSION 5 GRANTED—
Jul 8, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 13, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 12, 2025EXT5SOU EXTENSION 5 FILED—
Sep 6, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 6, 2024EX4GSOU EXTENSION 4 GRANTED—
Sep 6, 2024EXT4SOU EXTENSION 4 FILED—
Sep 6, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 19, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 19, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 19, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 19, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 19, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 19, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 15, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 14, 2024EX3GSOU EXTENSION 3 GRANTED—
Mar 14, 2024EXT3SOU EXTENSION 3 FILED—
Mar 14, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 19, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 17, 2023EX2GSOU EXTENSION 2 GRANTED—
Sep 17, 2023EXT2SOU EXTENSION 2 FILED—
Sep 17, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 8, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 8, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 9, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 7, 2023EX1GSOU EXTENSION 1 GRANTED—
Mar 7, 2023EXT1SOU EXTENSION 1 FILED—
Mar 7, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 14, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 14, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 14, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 27, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 2, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 2, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 13, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 30, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 28, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 26, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 26, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 26, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 25, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 24, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 24, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 20, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2022DOCKASSIGNED TO EXAMINER—
Oct 13, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 20, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance